A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.
Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.
Under guidance from the Oregon Health Authority, we have activated crisis standards of care in some care areas at Providence Oregon hospitals.
Many emergency rooms, clinics and urgent care centers are experiencing a sharp rise in the number of cases of RSV, flu and COVID.
Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence Portland Medical Center.
Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.
Providence is seeing many children with RSV. Under guidance from OHA, we have activated crisis standards of care in pediatric units at Providence St. Vincent Medical Center.
A joint statement from Kaiser Permanente, Legacy Health, OHSU Health and Providence
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
Learn about some changes that will be taking place at the Center for Medically Fragile Children, with an expansion of adult intermediate care.